A case presentation at the annual Transcatheter Valve Therapies conference showed positive outcomes from the use of Neovasc's experimental transcatheter device, Tiara, in treating a patient with severe heart conditions. The patient, a 79-year-old man who had poor left ventricular function, ischemic cardiomyopathy and severe mitral valve regurgitation, underwent implantation of the device and was recovering well at home seven weeks after the 30-minute procedure.
Case presentation shows positive results for Neovasc's transcatheter device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.